X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (36) 36
humans (35) 35
male (26) 26
oncology (26) 26
radiology, nuclear medicine & medical imaging (24) 24
middle aged (23) 23
aged (22) 22
female (18) 18
radiotherapy (17) 17
adult (14) 14
radiotherapy dosage (14) 14
aged, 80 and over (12) 12
cancer (12) 12
combined modality therapy (11) 11
prostatic neoplasms - radiotherapy (11) 11
radiation therapy (11) 11
radiology (10) 10
radiology and nuclear medicine (10) 10
carcinoma (9) 9
hematology, oncology and palliative medicine (9) 9
lung neoplasms - radiotherapy (9) 9
prostate cancer (9) 9
radiation (9) 9
patients (8) 8
survival analysis (8) 8
analysis of variance (7) 7
follow-up studies (7) 7
irradiation (7) 7
prostatic neoplasms - pathology (7) 7
article (6) 6
carcinoma, non-small-cell lung - radiotherapy (6) 6
chemotherapy (6) 6
lung neoplasms - drug therapy (6) 6
multivariate analysis (6) 6
retrospective studies (6) 6
survival (6) 6
survival rate (6) 6
carcinoma, non-small-cell lung - pathology (5) 5
carcinomas (5) 5
lung neoplasms - mortality (5) 5
lung neoplasms - pathology (5) 5
lungs (5) 5
neoplasm staging (5) 5
neoplasms (5) 5
prospective studies (5) 5
radiotherapy - adverse effects (5) 5
therapy (5) 5
time factors (5) 5
adenocarcinoma (4) 4
antineoplastic combined chemotherapy protocols - therapeutic use (4) 4
carcinoma, non-small-cell lung - drug therapy (4) 4
carcinoma, non-small-cell lung - mortality (4) 4
care and treatment (4) 4
cisplatin - administration & dosage (4) 4
lung cancer (4) 4
radiation doses (4) 4
radiation-therapy (4) 4
random allocation (4) 4
toxicity (4) 4
treatment outcome (4) 4
3-dimensional conformal radiotherapy (3) 3
adenocarcinoma - radiotherapy (3) 3
body (3) 3
breast neoplasms - radiotherapy (3) 3
breast neoplasms - surgery (3) 3
chemoradiotherapy (3) 3
clinical trials as topic (3) 3
diseases (3) 3
etoposide - administration & dosage (3) 3
lung cancer, non-small cell (3) 3
lymph node excision (3) 3
mastectomy (3) 3
medicine (3) 3
nuclear medicine (3) 3
nuclear radiation (3) 3
organs (3) 3
patient outcomes (3) 3
phase-iii trial (3) 3
prognosis (3) 3
prostatic neoplasms - mortality (3) 3
radical prostatectomy (3) 3
radiotherapy, high-energy (3) 3
surgery (3) 3
vinblastine - administration & dosage (3) 3
adenocarcinoma - drug therapy (2) 2
analysis (2) 2
androgen ablation (2) 2
androgen deprivation (2) 2
biomarkers, tumor - metabolism (2) 2
brain neoplasms - radiotherapy (2) 2
breast cancer (2) 2
carcinoma, small cell - drug therapy (2) 2
carcinoma, small cell - radiotherapy (2) 2
carcinoma, squamous cell - radiotherapy (2) 2
cells (2) 2
chemotherapy, adjuvant (2) 2
clinical trials (2) 2
combined therapy (2) 2
concurrent chemoradiation (2) 2
conformal radiotherapy (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 1, pp. 425 - 434
Purpose Patients treated with chemoradiotherapy for locally advanced non–small-cell lung carcinoma (LA-NSCLC) were analyzed for local-regional failure (LRF)... 
Radiology | Hematology, Oncology and Palliative Medicine | Survival with respect to radiotherapy dose intensity | Local-regional failure | Radiation oncology | Chemoradiotherapy | Advanced non–small-cell lung carcinoma | Advanced non-small-cell lung carcinoma | LEUKEMIA GROUP-B | INDUCTION CHEMOTHERAPY | CONSOLIDATION DOCETAXEL | COMPETING RISK | FOLLOW-UP | CANCER | PHASE-III TRIAL | ONCOLOGY | HYPERFRACTIONATED RADIATION | CONCURRENT CHEMORADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | THORACIC RADIOTHERAPY | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Vinblastine - administration & dosage | Cisplatin - administration & dosage | Carcinoma, Non-Small-Cell Lung - secondary | Treatment Failure | Aged, 80 and over | Adult | Female | Retrospective Studies | Paclitaxel - administration & dosage | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Chemoradiotherapy - methods | Proportional Hazards Models | Carboplatin - administration & dosage | Etoposide - administration & dosage | Lung Neoplasms - therapy | Carcinoma, Non-Small-Cell Lung - mortality | Carcinoma, Non-Small-Cell Lung - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Amifostine - administration & dosage | Aged | Relative Biological Effectiveness | Medical colleges | Care and treatment | Carcinoma | Nuclear radiation | Patient outcomes | Lung cancer, Non-small cell | Radiotherapy | Cancer | Statistical analysis | Lung | Radiation | Clinical trials | Non-small cell lung carcinoma | Data processing | Dose-response effects | Oncology | Radiation therapy | Multivariate analysis | Survival | Index Medicus | MULTIVARIATE ANALYSIS | PATIENTS | TESTING | FAILURES | LUNGS | CARCINOMAS | STANDARDS | RADIOLOGY AND NUCLEAR MEDICINE | RADIATION DOSES | RADIOTHERAPY | COMBINED THERAPY | HAZARDS | chemoradiotherapy | local-regional failure | Radiation Oncology | advanced non-small-cell lung carcinoma | survival with respect to radiotherapy dose intensity
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 80, Issue 1, pp. 301 - 305
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 1674 - 1679
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 3, pp. 802 - 808
Purpose Induction chemotherapy (ICT) improves survival compared with radiotherapy (RT) alone in locally advanced non–small-cell lung cancer (LANSCLC) patients... 
Radiology | Hematology, Oncology and Palliative Medicine | Induction chemotherapy | Radiation Therapy Oncology Group | locally advanced non–small-cell lung cancer | RTOG | concurrent chemoradiotherapy | locally advanced non-small-cell lung cancer | LEUKEMIA GROUP-B | STAGE-IIIA | CARBOPLATIN | CHEMORADIOTHERAPY | PACLITAXEL | PHASE-III TRIAL | THERAPY | ONCOLOGY | CONFORMAL RADIOTHERAPY | CONCURRENT CHEMORADIATION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | COOPERATIVE-ONCOLOGY-GROUP | Carcinoma, Non-Small-Cell Lung - pathology | Radiotherapy Dosage | Carcinoma, Non-Small-Cell Lung - radiotherapy | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | Lung Neoplasms - radiotherapy | Lung Neoplasms - pathology | Male | Combined Modality Therapy | Vinblastine - administration & dosage | Carcinoma, Non-Small-Cell Lung - mortality | Remission Induction | Cisplatin - administration & dosage | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Aged, 80 and over | Adult | Female | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Neoplasm Staging | Chemotherapy | Prognosis | Patient outcomes | Radiation | Lung cancer, Non-small cell | Radiotherapy | Cancer | Index Medicus | AZOLES | LUNGS | VINBLASTINE | HETEROCYCLIC COMPOUNDS | MEDICINE | MATHEMATICS | MULTIVARIATE ANALYSIS | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | AROMATICS | RADIOTHERAPY | ORGANIC NITROGEN COMPOUNDS | COMBINED THERAPY | RADIOLOGY | NEOPLASMS | ORGANIC COMPOUNDS | STATISTICS | ANTIMITOTIC DRUGS | PYRROLES | CHEMOTHERAPY | INDOLES | NUCLEAR MEDICINE | DOSE-RESPONSE RELATIONSHIPS | ORGANS | DISEASES | RESPIRATORY SYSTEM | BODY | AZAARENES | SURVIVAL CURVES | ALKALOIDS
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2007, Volume 69, Issue 4, pp. 985 - 992
Journal Article
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, ISSN 1556-0864, 4/2012, Volume 7, Issue 4
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 1998, Volume 42, Issue 1, pp. 110 - 110
Journal Article
Journal Article